Zenas Biopharma Inc (NASDAQ: ZBIO) on Friday, soared 20.79% from the previous trading day, before settling in for the closing price of $16.98. Within the past 52 weeks, ZBIO’s price has moved between $5.83 and $26.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 71.19%. With a float of $10.07 million, this company’s outstanding shares have now reached $42.09 million.
Zenas Biopharma Inc (ZBIO) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Zenas Biopharma Inc is 76.09%, while institutional ownership is 35.90%. The most recent insider transaction that took place on Feb 18 ’25, was worth 166,750. In this transaction Chief Executive Officer of this company bought 25,000 shares at a rate of $6.67, taking the stock ownership to the 266,155 shares. Before that another transaction happened on Feb 07 ’25, when Company’s Director bought 10,000 for $7.76, making the entire transaction worth $77,600. This insider now owns 47,000 shares in total.
Zenas Biopharma Inc (NASDAQ: ZBIO) Trading Performance Indicators
Zenas Biopharma Inc (ZBIO) is currently performing well based on its current performance indicators. A quick ratio of 5.23 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 57.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.23, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -4.33 in one year’s time.
Technical Analysis of Zenas Biopharma Inc (ZBIO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.3 million. That was better than the volume of 0.19 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.50%.
During the past 100 days, Zenas Biopharma Inc’s (ZBIO) raw stochastic average was set at 100.00%, which indicates a significant increase from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.39 in the past 14 days, which was higher than the 1.12 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.61, while its 200-day Moving Average is $10.53. However, in the short run, Zenas Biopharma Inc’s stock first resistance to watch stands at $21.67. Second resistance stands at $22.83. The third major resistance level sits at $25.15. If the price goes on to break the first support level at $18.19, it is likely to go to the next support level at $15.87. The third support level lies at $14.71 if the price breaches the second support level.
Zenas Biopharma Inc (NASDAQ: ZBIO) Key Stats
Market capitalization of the company is 863.68 million based on 42,110K outstanding shares. Right now, sales total 5,000 K and income totals -156,990 K. The company made 10,000 K in profit during its latest quarter, and -33,570 K in sales during its previous quarter.
